Targeting the Eph System with Peptides and Peptide Conjugates.

Area of Science:

• Cellular Biology
• Molecular Biology
• Pharmacology

Background:

• Eph receptor tyrosine kinases and ephrin ligands are crucial for cell communication, impacting development, tissue homeostasis, and disease.
• Dysregulated Eph receptor/ephrin expression is observed in various pathological conditions, highlighting their significance as drug targets.

Purpose of the Study:

• To explore the potential of peptide-based agents for targeting Eph receptors, focusing on their binding pocket characteristics.
• To review advancements in peptide design, including cyclic scaffolds, for enhanced affinity, selectivity, and pharmacokinetic properties.

Main Methods:

• Identification of Eph receptor-binding peptides using techniques like phage display.
• Characterization of peptide binding affinity, selectivity, and functional effects (antagonist/agonist activity).
• Optimization of peptide scaffolds (e.g., cyclic peptides) for improved drug-like properties.

Main Results:

• Peptides can bind to the Eph receptor extracellular pocket with high affinity and selectivity.
• Optimized peptides exhibit low nanomolar binding affinity, protease resistance, and long in vivo half-life.
• Peptides can act as agonists or antagonists, modulating Eph receptor/ephrin signaling.

Conclusions:

• Peptides represent a viable therapeutic modality for targeting Eph receptors due to their tunable properties.
• Advanced peptide designs, particularly cyclic peptides, show significant promise for developing novel drugs and targeted delivery systems.
• Peptides can be utilized for targeted delivery of imaging agents or therapeutics to Eph receptor-expressing tissues, such as tumors.